Announcement! Coronavirus Vaccine Trial Begins Today - Coronavirus vaccine trials will be conducted today in the US. This was confirmed by local officials who declined to be named on Sunday (3/15/2020).
Quoted from the AP, the first participant will begin injecting the vaccine with a specific dose. He is a 45-year-old volunteer with a healthy body condition.
Even so, the vaccine will not contain the virus. The manufacture of the vaccine was funded by the National Institutes of Health (NIH) at the Kaiser Permanente Washington Health Research Institute in Seattle.
Even so, the vaccine will not contain the virus. The manufacture of the vaccine was funded by the National Institutes of Health (NIH) at the Kaiser Permanente Washington Health Research Institute in Seattle.
 |
| Credits: Pixabay |
The purpose of this experiment itself is only at the point of seeing the side effects of vaccines. But the vaccine will not be officially announced to the public.
According to Dr. Anthony Fauci, Director of the NIH National Institute, this test will still take one to one and a half years. Even if the initial safety test goes well.
At present many research groups around the world are racing to make the COVID-19 vaccine. Some researchers have made temporary vaccines that can protect for up to two months.
Inivio Pharmaceuticals, for example, will begin corona vaccine testing next week. Several volunteers are willing to participate in research, including at the University of Pennsylvania and the Kansas City Research Center.
Similar research is also reportedly carried out by other countries such as China and South Korea. Israel also claimed it was conducting a trial.
Meanwhile, US President Donald Trump is pushing for rapid vaccine manufacturing. "Right away," he said.
According to Dr. Anthony Fauci, Director of the NIH National Institute, this test will still take one to one and a half years. Even if the initial safety test goes well.
At present many research groups around the world are racing to make the COVID-19 vaccine. Some researchers have made temporary vaccines that can protect for up to two months.
Inivio Pharmaceuticals, for example, will begin corona vaccine testing next week. Several volunteers are willing to participate in research, including at the University of Pennsylvania and the Kansas City Research Center.
Similar research is also reportedly carried out by other countries such as China and South Korea. Israel also claimed it was conducting a trial.
Meanwhile, US President Donald Trump is pushing for rapid vaccine manufacturing. "Right away," he said.
